Literature DB >> 7509737

Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma.

C Lassarre1, M Binoux.   

Abstract

In a variety of physio-pathological conditions, but also in the normal state, calcium-dependent serine protease(s) partially proteolyze proportions of circulating insulin-like growth factor binding protein-3 (IGFBP-3). This occurs without disrupting the 150-kilodalton (kDa) complexes in which IGFBP-3 carries of most of the IGF-I and IGF-II in serum. In this work we show that the 150-kDa complex is functionally altered during pregnancy, which is when the largest proportion of IGFBP-3 is proteolyzed. After preincubation at 4 C with [125I]IGF-I or -II with or without 1 microgram unlabeled IGF-I or -II, pooled plasma samples were gel filtered at pH 7.4. Larger proportions of labeled IGFs were found in the 150-kDa complexes of the third trimester pregnancy plasma pool than in those of the normal plasma pool, suggesting increased binding capacity. Nevertheless, competitive binding experiments using [125I]IGF-I and -II and IGFBP-3 preparations from each of the plasma pools showed that the competitive potencies of IGF-II and especially IGF-I were lower in pregnancy IGFBP-3 than in normal IGFBP-3. Scatchard analysis revealed a 2-fold loss of affinity for IGF-II and a 10-fold loss for IGF-I compared with that for normal plasma IGFBP-3. In studies at 37 C of the kinetics of dissociation of [125I]IGF-I and -II bound to IGFBP-3, IGF-II was dissociated 6 times faster, and IGF-I 10 times faster from pregnancy plasma IGFBP-3 than from normal plasma IGFBP-3. After incubation of individual plasma samples at 37 C and gel filtration at room temperature (in the presence of EDTA), IGFs were assayed in the three circulating pools (150-kDa and 40-kDa complexes and free IGFs), revealing a redistribution of pregnancy plasma IGFs. The proportion of total IGF-I in free form was nearly three times greater in pregnancy than in normal plasma (11.4% vs. 4.1%, P < 0.005), whereas that of free IGF-II was slightly smaller (1.5% vs. 2%). In the 150-kDa complexes, the proportion of total IGF-I was significantly smaller in pregnancy than in normal plasma, and that of IGF-II was greater. In the 40-kDa complexes, the proportion of total IGF-II was significantly smaller. The mean ratios of molar concentrations of free IGF-I/IGF-II were 0.43 in normal plasma and 2.23 in pregnancy plasma (P < 0.005).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509737     DOI: 10.1210/endo.134.3.7509737

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

Review 1.  Genetics, chemistry, and function of the IGF/IGFBP system.

Authors:  P F Collett-Solberg; P Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.633

2.  An expression of IGF-binding proteins in normal and pre-eclamptic human umbilical cord serum and tissues.

Authors:  Edward Bańkowski; Jerzy Pałka; Stefan Jaworski
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

3.  In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells.

Authors:  C Blat; J Villaudy; M Binoux
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  Insulin-like growth factor II signaling through the insulin-like growth factor II/mannose-6-phosphate receptor promotes exocytosis in insulin-secreting cells.

Authors:  Q Zhang; M Tally; O Larsson; R T Kennedy; L Huang; K Hall; P O Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

5.  Amino acid infusion during anesthesia attenuates the surgery induced decline in IGF-1 and diminishes the "diabetes of injury".

Authors:  Mats K E B Wallin; Eva Selldén; Staffan Eksborg; Kerstin Brismar
Journal:  Nutr Metab (Lond)       Date:  2007-01-09       Impact factor: 4.169

6.  Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1.

Authors:  D C Martin; J L Fowlkes; B Babic; R Khokha
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

7.  Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer.

Authors:  S I Helle; J Geisler; G B Anker; B Leirvaag; J M Holly; P E Lønning
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

8.  Increased Concentrations of Insulin-Like Growth Factor Binding Protein (IGFBP)-2, IGFBP-3, and IGFBP-4 Are Associated With Fetal Mortality in Pregnant Cows.

Authors:  Kirsten Mense; Julia Heidekorn-Dettmer; Elisa Wirthgen; Yette Brockelmann; Ralf Bortfeldt; Sarah Peter; Markus Jung; Christine Höflich; Andreas Hoeflich; Marion Schmicke
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-12       Impact factor: 5.555

9.  Insulin-like growth factor axis in pregnancies affected by fetal growth disorders.

Authors:  Aamod R Nawathe; Mark Christian; Sung Hye Kim; Mark Johnson; Makrina D Savvidou; Vasso Terzidou
Journal:  Clin Epigenetics       Date:  2016-01-27       Impact factor: 6.551

Review 10.  Pregnancy-Associated Plasma Protein (PAPP)-A2 in Physiology and Disease.

Authors:  Vicente Barrios; Julie A Chowen; Álvaro Martín-Rivada; Santiago Guerra-Cantera; Jesús Pozo; Shoshana Yakar; Ron G Rosenfeld; Luis A Pérez-Jurado; Juan Suárez; Jesús Argente
Journal:  Cells       Date:  2021-12-18       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.